We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALLK market cap is 96.66M. The company's latest EPS is USD -2.1133 and P/E is -0.52.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.45M | -46.22M | -45.05M | -37.82M | -48.21M |
| Net Income | -30.84M | -42.99M | -42.4M | -35.12M | -45.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -91.42M | -157.06M | -271.48M | -322.43M | -196.06M |
| Net Income | -85.37M | -153.48M | -269.86M | -319.95M | -185.7M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 418.57M | 386.42M | 350.41M | 319.2M | 283.5M |
| Total Liabilities | 74.39M | 75.99M | 69.96M | 64.22M | 62.45M |
| Total Equity | 344.18M | 310.43M | 280.45M | 254.98M | 221.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 516.89M | 719.62M | 534.82M | 386.42M | 243.61M |
| Total Liabilities | 21.17M | 65.22M | 89.35M | 75.99M | 74.79M |
| Total Equity | 495.72M | 654.4M | 445.48M | 310.43M | 168.82M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -233.19M | -279.97M | -30.14M | -62.73M | -92.21M |
| Investing | 143.16M | 71.68M | 35.32M | 41.44M | 72.99M |
| Financing | 141.69M | 141.88M | 1.46M | 1.46M | 2.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.01M | -113.92M | -207.85M | -279.97M | -116.48M |
| Investing | -311.97M | 3.9M | 143.24M | 71.68M | 93.18M |
| Financing | 381.16M | 278.84M | 10.26M | 141.88M | 2.53M |
| Market Cap | 96.66M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.45 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 87.87M |
| Average Volume (1 week) | 440.78k |
| Average Volume (1 Month) | 408.05k |
| 52 Week Change | -75.00% |
| 52 Week High | 5.64 |
| 52 Week Low | 0.9799 |
| Spread (Intraday) | 0.08 (7.02%) |
| Company Name | Allakos Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.allakos.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
